Article Text
PostScript
Letters
Author's response to Spectral-domain optical coherence tomography in subjects over 60 years of age, and its implications for designing clinical trials
Statistics from Altmetric.com
Footnotes
-
Contributors Sole author.
-
Funding Received research support from Bausch&Lomb, Fluoron GmbH and Alamedics GmbH.
-
Competing interests None.
-
Patient consent Obtained.
-
Ethics approval University of Cologne.